Hikma Pharmaceuticals's market cap is currently $4.74B. The company's EPS TTM is $2.168; its P/E ratio is 12.86; and it has a dividend yield of 3.91%. Hikma Pharmaceuticals is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in USD
Hikma Pharmaceuticals Earnings and Revenue History
